
    
      This is a prospective, non-randomized, multi-center trial for patients undergoing aortic
      valve replacement with the Edwards SAPIEN 3 THV for severe aortic stenosis. Patient cohorts
      will include those inoperable and those considered as a high surgical risk (STS â‰¥8%). The
      study also includes NR7 patients (patients with a 20mm vessel size).
    
  